Yes, Zepbound is approved for weight loss
MOTS-c: A promising mitochondrial-derived peptide for therapeutic exploitation
Plaintiffs have filed lawsuits against Novo Nordisk and other drug companies, alleging that all versions of these drugs carried significant risks and that the companies failed to adequately warn consumers
Commercial health plans have in place prior authorization requirements to try to limit coverage of new weight-loss shots to those who qualify for these treatments
He said, if you ask people, Would you rather take a pill or an injection? People overwhelmingly prefer a pill. He added, however, that people might not feel the same way if the pills are more costly than the injections
Overall, digestive adverse events were reported in 74% of patients taking oral semaglutide, compared to 42.2% on placebo (inactive pill)